Qiming U.S. Healthcare Fund II, L.P.

Qiming U.S. Healthcare Fund II, L.P. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Icosavax, Inc., Elevation Oncology, Inc. and Jasper Therapeutics, Inc. In total, 8 filings cover trades dated from 29 June 2021 to 27 January 2023.

Purchases make up the whole of the open-market record (5 purchases, €10.7M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2023, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €2.5M. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 11 April 2023, the filings show an open-market purchase worth €3.7M in Jasper Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.